185 related articles for article (PubMed ID: 24961937)
1. Concomitant inhibition of oxidative stress and angiogenesis by chronic hydrogen-rich saline and N-acetylcysteine treatments improves systemic, splanchnic and hepatic hemodynamics of cirrhotic rats.
Lee PC; Yang YY; Huang CS; Hsieh SL; Lee KC; Hsieh YC; Lee TY; Lin HC
Hepatol Res; 2015 May; 45(5):578-88. PubMed ID: 24961937
[TBL] [Abstract][Full Text] [Related]
2. The beneficial effects of curcumin in cirrhotic rats with portal hypertension.
Hsu SJ; Lee JY; Lin TY; Hsieh YH; Huang HC; Lee FY; Lin HC; Hou MC; Lee SD
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29162665
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats.
Huang HC; Wang SS; Hsin IF; Chang CC; Lee FY; Lin HC; Chuang CL; Lee JY; Hsieh HG; Lee SD
Hepatology; 2012 Jul; 56(1):248-58. PubMed ID: 22290687
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats.
Schwabl P; Payer BA; Grahovac J; Klein S; Horvatits T; Mitterhauser M; Stift J; Boucher Y; Trebicka J; Trauner M; Angermayr B; Fuhrmann V; Reiberger T; Peck-Radosavljevic M
J Hepatol; 2014 Jun; 60(6):1135-42. PubMed ID: 24530596
[TBL] [Abstract][Full Text] [Related]
5. Microbiota transplants from feces or gut content attenuated portal hypertension and portosystemic collaterals in cirrhotic rats.
Huang HC; Tsai MH; Chang CC; Pun CK; Huang YH; Hou MC; Lee FY; Hsu SJ
Clin Sci (Lond); 2021 Dec; 135(24):2709-2728. PubMed ID: 34870313
[TBL] [Abstract][Full Text] [Related]
6. Insulin reverses major portal hypertension-related derangements in rats with liver cirrhosis and diabetes.
Hsin IF; Huang HC; Chang CC; Hsu SJ; Lee FY; Huo TI; Chuang CL; Hou MC; Lee SD
Clin Sci (Lond); 2018 Nov; 132(22):2391-2405. PubMed ID: 30348829
[TBL] [Abstract][Full Text] [Related]
7. Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats.
Hsu SJ; Lee FY; Wang SS; Hsin IF; Lin TY; Huang HC; Chang CC; Chuang CL; Ho HL; Lin HC; Lee SD
Hepatology; 2015 May; 61(5):1672-84. PubMed ID: 25557829
[TBL] [Abstract][Full Text] [Related]
8. Glycyrrhizin Attenuates Portal Hypertension and Collateral Shunting via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats.
Pun CK; Huang HC; Chang CC; Chuang CL; Yen CH; Hsu SJ; Lee FY; Hou MC; Huang YH
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299285
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide Improves the Intestinal Mucosal Injury and Suppresses Mesenteric Angiogenesis and Vasodilatation by Down-Regulating Inflammasomes-Related Cascades in Cirrhotic Rats.
Li TH; Huang CC; Yang YY; Lee KC; Hsieh SL; Hsieh YC; Alan L; Lin HC; Lee SD; Tsai CY
PLoS One; 2016; 11(1):e0147212. PubMed ID: 26820153
[TBL] [Abstract][Full Text] [Related]
10. Folic acid ameliorates homocysteine-induced angiogenesis and portosystemic collaterals in cirrhotic rats.
Ho HL; Tsai MH; Hsieh YH; Huo TI; Chang CC; Lee FY; Huang HC; Hou MC; Lee SD
Ann Hepatol; 2019; 18(4):633-639. PubMed ID: 31078441
[TBL] [Abstract][Full Text] [Related]
11. Cediranib ameliorates portal hypertensive syndrome via inhibition of VEGFR-2 signaling in cirrhotic rats.
Fan Q; Wu G; Chen M; Luo G; Wu Z; Huo H; Li H; Zheng L; Luo M
Eur J Pharmacol; 2024 Feb; 964():176278. PubMed ID: 38158116
[TBL] [Abstract][Full Text] [Related]
12. Green tea polyphenol decreases the severity of portosystemic collaterals and mesenteric angiogenesis in rats with liver cirrhosis.
Hsu SJ; Wang SS; Hsin IF; Lee FY; Huang HC; Huo TI; Lee WS; Lin HC; Lee SD
Clin Sci (Lond); 2014 May; 126(9):633-44. PubMed ID: 24063570
[TBL] [Abstract][Full Text] [Related]
13. NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats.
Angermayr B; Fernandez M; Mejias M; Gracia-Sancho J; Garcia-Pagan JC; Bosch J
Gut; 2007 Apr; 56(4):560-4. PubMed ID: 16854998
[TBL] [Abstract][Full Text] [Related]
14. Endothelin receptor blockers reduce shunting and angiogenesis in cirrhotic rats.
Hsu SJ; Lin TY; Wang SS; Chuang CL; Lee FY; Huang HC; Hsin IF; Lee JY; Lin HC; Lee SD
Eur J Clin Invest; 2016 Jun; 46(6):572-80. PubMed ID: 27091078
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats.
Mejias M; Garcia-Pras E; Tiani C; Miquel R; Bosch J; Fernandez M
Hepatology; 2009 Apr; 49(4):1245-56. PubMed ID: 19137587
[TBL] [Abstract][Full Text] [Related]
16. Lycopene treatment improves intrahepatic fibrosis and attenuates pathological angiogenesis in biliary cirrhotic rats.
Huang HC; Hsu SJ; Chang CC; Kao YC; Chuang CL; Hou MC; Lee FY
J Chin Med Assoc; 2022 Apr; 85(4):414-420. PubMed ID: 35120355
[TBL] [Abstract][Full Text] [Related]
17. Ascorbate lacks significant influence in rats with bile duct ligation-induced liver injury.
Ho HL; Huo TI; Chang T; Lee WS; Hsin IF; Lee FY; Huang HC; Hou MC; Lee SD
J Chin Med Assoc; 2017 Sep; 80(9):539-550. PubMed ID: 28684188
[TBL] [Abstract][Full Text] [Related]
18. Beneficial Effects of the Peroxisome Proliferator-Activated Receptor α/γ Agonist Aleglitazar on Progressive Hepatic and Splanchnic Abnormalities in Cirrhotic Rats with Portal Hypertension.
Tsai HC; Li TH; Huang CC; Huang SF; Liu RS; Yang YY; Hsieh YC; Lee KC; Huang YH; Hou MC; Lin HC
Am J Pathol; 2018 Jul; 188(7):1608-1624. PubMed ID: 29929914
[TBL] [Abstract][Full Text] [Related]
19. Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats.
Chang T; Ho HL; Hsu SJ; Chang CC; Tsai MH; Huo TI; Huang HC; Lee FY; Hou MC; Lee SD
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31454890
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine deteriorates intrahepatic derangement and portal-systemic collaterals in cirrhotic rats.
Tung HC; Hsu SJ; Tsai MH; Lin TY; Hsin IF; Huo TI; Lee FY; Huang HC; Ho HL; Lin HC; Lee SD
Clin Sci (Lond); 2017 Jan; 131(1):69-86. PubMed ID: 27803296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
